A
Achieve Life Sciences (ACHV)
$000.00 0.00% ($0.00)
- Today
- Week
- Month
- Year
- 5 Year
- YTD
getbaraka.com
About Achieve Life Sciences (ACHV)
Achieve Life Sciences, Inc. is a late-stage clinical pharmaceutical company engaged in the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence. The Company’s product candidate, cytisinicline, is a n... Read more
- USD3.35
- USD3.35
- USD3.12
- USD5.59
- -19.00%
- --
- 179.73k
- 289.69k
- 116M
- 3.26
- -22.60%
Stock News
6 hours ago
Companies are expected to post their best earnings growth in 3 years. The biggest gains won’t come from Big Tech.
MarketWatch
yesterday
Jim Cramer says he supports healthcare stocks for their long-term value
CNBC
yesterday
What's behind the move in AI infrastructure stocks — plus, Meta sticks with efficiency mantra
CNBC
yesterday
Eli Lilly shares tumble after cutting its sales outlook. What it means for investors
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
